Suzhou Basecare Medical Corporation Limited

SEHK:2170 Stock Report

Market Cap: HK$738.5m

Suzhou Basecare Medical Future Growth

Future criteria checks 1/6

Suzhou Basecare Medical is forecast to grow earnings and revenue by 46.5% and 17.3% per annum respectively. EPS is expected to grow by 46.1% per annum. Return on equity is forecast to be -8.1% in 3 years.

Key information

46.5%

Earnings growth rate

46.1%

EPS growth rate

Medical Equipment earnings growth41.0%
Revenue growth rate17.3%
Future return on equity-8.1%
Analyst coverage

Low

Last updated02 Jul 2024

Recent future growth updates

Recent updates

Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Nov 18
Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S

Sep 27
Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S

Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

May 30
Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story

May 09
Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story

Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch

Mar 22
Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch

Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?

Aug 01
Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?

Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop

May 26
Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop

Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?

Jul 20
Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?

Earnings and Revenue Growth Forecasts

SEHK:2170 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026374-62-55-251
12/31/2025318-117-137-1171
12/31/2024262-160-199-1891
6/30/2024247-250-375-266N/A
3/31/2024228-221-373-267N/A
12/31/2023208-192-371-267N/A
9/30/2023183-176N/AN/AN/A
6/30/2023158-160-331-220N/A
3/31/2023149-146-324-205N/A
12/31/2022141-132-317-189N/A
9/30/2022133-133N/AN/AN/A
6/30/2022126-135-310-219N/A
3/31/2022117-139-268-208N/A
12/31/2021107-144-227-198N/A
9/30/2021103-119-172-151N/A
6/30/202199-106-119-107N/A
3/31/202190-490-96-86N/A
12/31/202081-874-72-64N/A
9/30/202071-1,008-56-51N/A
6/30/202061-1,116-62-58N/A
3/31/202058-822-51-48N/A
12/31/201956-528-41-38N/A
12/31/201833-152-31-27N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2170 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 2170 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 2170 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 2170's revenue (17.3% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2170's revenue (17.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2170 is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:37
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suzhou Basecare Medical Corporation Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiaying FuChina International Capital Corporation Limited
Shuo SongCitic Securities Co., Ltd.
Mujun ShenCitic Securities Co., Ltd.